SCHEMBL28356274

SCHEMBL28356274

Cc1ccc(-c2cccc(O)c2)c(C)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 10/20 0.49
HSD17B2 P37059 10/20 0.49
ESR2 Q92731 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 2/20 0.47
ALDH1A1 P00352 1/20 0.46
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 2/20 0.42
ACHE P22303 1/20 0.42
ESR1 P03372 2/20 0.41
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2B6 P20813 1/20 0.40
MGAM O43451 1/20 0.40
GAA P10253 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11359920 0.81 HSD17B1 (0.52) HSD17B1HSD17B2ESR2CYP3A4CYP2C9
SCHEMBL1513737 0.80 ESR2 (0.53) ESR2ALDH1A1CYP2B6
SCHEMBL10306739 0.79 HSD17B1 (0.54) HSD17B1HSD17B2ESR2CYP3A4CYP2C9
SCHEMBL922255 0.78 CA1 (0.56) ESR2CYP3A4CYP2C9ALDH1A1CYP2D6
Resorcinol SCHEMBL10383035 0.78 ALDH1A1 (0.55) HSD17B1HSD17B2CYP3A4CYP2C9ALDH1A1
SCHEMBL30963936 0.78 ESR2 (0.52) HSD17B1HSD17B2ESR2CYP3A4CYP2C9
SCHEMBL4191598 0.77 HSD17B1 (0.52) HSD17B1HSD17B2ESR2CYP3A4CYP2C9
Resorcinol SCHEMBL357511 0.75 ALDH1A1 (0.74) HSD17B1HSD17B2CYP3A4CYP2C9ALDH1A1
SCHEMBL31547671 0.75 POLB (0.48) ESR2CYP3A4CYP2C9ALDH1A1CYP2D6
SCHEMBL920891 0.75 POLB (0.48) ESR2CYP3A4CYP2C9ALDH1A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110799509-A PD-1/PD-L1 inhibitors 吉利德科学公司 2020-02-14 CN disclosed